Stephen Mok
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
Papers in
- Immunology 18
- Immunotherapy and Immune Responses 10
- Immune cells in cancer 9
- Immune Cell Function and Interaction 6
- Oncology 16
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 6
- Co-authors
- Antoni Ribas (17 shared papers)Richard C. Koya (14 shared papers)Thomas G. Graeber (6 shared papers)Lídia Robert (5 shared papers)Brian L. West (3 shared papers)Gideon Bollag (3 shared papers)Jingying Xu (2 shared papers)Lily Wu (2 shared papers)
- Journals
- Cancer Research (9 papers)Proceedings of the National Academy of Sciences (3 papers)Cancer Immunology Research (2 papers)Clinical Cancer Research (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- United StatesSingaporePoland
In The Last Decade
Stephen Mok
32 papers receiving 2.7k citations
Stephen Mok's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 1.8k
- Immunology 1.4k
- Molecular Biology 843
- Cancer Research 124
- Pathology and Forensic Medicine 121
Countries citing papers authored by Stephen Mok
This map shows the geographic impact of Stephen Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Mok more than expected).
Fields of papers citing papers by Stephen Mok
This network shows the impact of papers produced by Stephen Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Mok. The network helps show where Stephen Mok may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Mok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 479 | |
| 2 | Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma Hit paper breakdown → | 2015 | 452 |
| 3 | 2014 | 293 | |
| 4 | 2013 | 256 | |
| 5 | 2015 | 244 | |
| 6 | 2012 | 189 | |
| 7 | 2010 | 178 | |
| 8 | 2011 | 126 | |
| 9 | 2009 | 122 | |
| 10 | 2015 | 83 | |
| 11 | 2014 | 67 | |
| 12 | 2012 | 64 | |
| 13 | 2010 | 49 | |
| 14 | 2015 | 48 | |
| 15 | 2008 | 18 | |
| 16 | 2024 | 8 | |
| 17 | 2025 | 8 | |
| 18 | 2012 | 7 | |
| 19 | 2017 | 5 | |
| 20 | 2016 | 4 |
About Stephen Mok
Stephen Mok is a scholar working on Immunology, Oncology, Molecular Biology, Building and Construction and Organic Chemistry, having authored 32 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (10 papers), Immune cells in cancer (9 papers), Melanoma and MAPK Pathways (7 papers), Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (6 papers), Building Energy and Comfort Optimization (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (1.4k citations), Molecular Biology (843 citations), Cancer Research (124 citations) and Pathology and Forensic Medicine (121 citations). Stephen Mok has collaborated with scholars based in United States, Singapore and Poland. Frequent co-authors include Antoni Ribas, Richard C. Koya, Thomas G. Graeber, Lídia Robert, Brian L. West, Gideon Bollag, Jingying Xu, Lily Wu, Begoña Comı́n-Anduix and Jennifer Tsoi. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Cancer Immunology Research, Clinical Cancer Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.